08:30

WELCOME + INTRODUCTION
Tore Curstedt, Stockholm, Sweden; Henry L. Halliday, Belfast, UK

08:45

11^th BENGT ROBERTSON MEMORIAL LECTURE
Bronchopulmonary dysplasia: 50 years after the original description
Eduardo Bancalari, Miami, USA

09:30

LESSONS FROM THE PAST
Henry L. Halliday, Belfast, UK

10:00

Discussion

10:15

COFFEE BREAK

Chairpersons: Haresh Kirpalani, Halifax, Canada; Charles C. Roehr, Oxford, UK

10:45

THE CHANGING LANDSCAPE IN SUPPORTING PRETERM INFANTS AT BIRTH
Arjan B. te Pas, Leiden, The Netherlands

11:15

THE GOLDEN MINUTE IN THE DELIVERY ROOM: WHAT IS NEEDED?
Ola D. Saugstad, Oslo, Norway

11:45

Discussion

12:00

FREE COMMUNICATIONS

12:00

In vivo tracing of pulmonary exogenous surfactant by 13C natural abundance approach
S. Giambelluca¹, F. Ricci², M. Simonato¹, L. Vedovelli¹, A. Correani³, C. Casiraghi², M. Storti², A. Mersanne², P. Cogo⁴, F. Salomone², V. P. Carnielli³ (¹Padova; ²Parma; ³Ancona; ⁴Udine, Italy)

12:15

Drug induced regulated hypothermia using VH-N439, a neurotensin analogue conjugated to a brain penetrant peptide: A study in newborn piglets
G. Jacquot¹, R. Solberg², M. Masse¹, J. Barlinn², B. Dotinga², M. Melheim², P. Lecorche¹, J. Temsamani¹, M. Khrestchatisky¹, O.D. Saugstad^{2 (1}Marseille, France; ²Oslo, Norway)

12:30

LUNCH BREAK

Chairpersons: Eren Özek, Istanbul, Turkey; Henrik Verder, Holbæk, Denmark

13:30

POSTER PRESENTATIONS

Is nasal septum-tragus length measurement safer in determining endotracheal intubation depth in neonates?
O. Uygur¹, M.Y. Oncel¹, G. Kadioglu Simsek², N. Okur³, K. Celik³, O. Bozkurt⁴ et al (¹Izmir; ²Ankara; ³Diyarbakır; ⁴Şanlıurfa, Turkey)

Short term outcome of late preterm infants compared to term infants – a case-control study
C. Zgârcea, M.L. Ognean, O. Boantă, C. Vlad, A. Ștefan, S. Bunescu, R. Chicea (Sibiu, Romania)

Therapeutic hypothermia: Brazilian experience
R.S. Procianoy, A.L.Corso, B.O. Shoenardie, G.P. de Oliveira, R.C. Silveira (Porto Alegre, Brazil)

Random forest machine learning based prediction of late-onset sepsis and necrotising enterocolitis in preterm infants by using pulse oximetry time series data
N. Aladağ Çiftdemir, I.Güzey, B.Acunaş, Ö.Uçar (Edirne, Turkey)

Conservative versus medical management: Turkish national registry on treatment option and its timing in patent ductus arteriosus (INTERPDA trial)
E.Okulu¹, O. Erdeve¹, Z. Arslan¹, D.U. Usik¹, H. Kaya²,I.K. Gocke² et al (¹ Ankara; ² Malatya,Turkey)

Transcriptome profiling of lung development and hyperoxia-induced lung-injury in a preterm rabbit model of bronchopulmonary dysplasia
M.Storti¹, B. Montanini¹, F. Ricci¹, C. Casiraghi¹, A. Mersanne¹, M. Lucattelli² et al. (¹Parma, ²Siena, Italy)

TGFβ regulates the establishment of pulmonary alveolar stem cell niche
P. Minoo, R. Ramanathan (Los Angeles, USA)

Chairpersons: Dominique Haumont, Brussels, Belgium; Umberto Simeoni, Lausanne, Switzerland

14:30

EVIDENCE BASED SUPPORT OF THE RED CELL MASS IN EXTREMELY PRETERM INFANTS
Haresh Kirpalani, Hamilton, Canada

15:00

WORK IN PROGRESS –  FREE COMMUNICATIONS

Optimizing neonatal care at the Saint Camille Hospital, Ouagadougou (Hosco), Burkina Faso – impact of the neonatal essential survival technology (NEST) continuous quality improvement (QI) program
P. Ouedraogo¹, V. Bissyande¹, P.E. Villani², L. Tubaldi³, J. Bua⁴, F. Uxa ⁵, C. Dell’Anna⁶, M.A. Thomson⁷, C. Plicco⁸, M.P. Chiesi ⁸ (¹Ouagadougou, Burkina Faso; ²Brescia; ³Macerata; ⁴Trieste, Italy; ⁶Cary, USA; ⁷Uxbridge, UK; ⁸Parma, Italy)

15:30

Maternal paracetamol preceeding preterm delivery associated with umbilical cord PH
A. Laitala, T. Saarela, O. Aikio, M. Hallman (Oulu, Finland)

15:45

COFFEE BREAK

16:15

IMMUNO-NUTRITION FOR PRETERM INFANTS
William Mc Guire, York, UK

16:45

PRETERM NUTRITION: STILL CONTROVERSIAL AFTER ALL THESE YEARS
Neena Modi, London, UK

17:15

Discussion

17:45

Adjourn

Chairpersons: Mikko Hallman, Oulu, Finland; Christian P. Speer, Wuerzburg,Germany

08:30

DEVELOPMENT OF SYNTHETIC SURFACTANT FOR CLINICAL USE
Tore Curstedt, Stockholm, Sweden

09:00

CLINICAL TRIALS WITH SYNTHETIC SURFACTANT
David G. Sweet, Belfast, UK

09:30

NOVEL SURFACTANT ADMINISTRATION TECHNIQUES: WILL THEY CHANGE OUTCOME?
Roger Soll, Burlington, USA

10:00

Discussion

10:30

COFFEE BREAK

11:00

FREE COMMUNICATIONS

Chairpersons: Jan Johansson, Huddinge, Sweden; Richard Plavka, Prague, Czech Republic

11:00

Efficacy and safety of synthetic surfactant (CHF5633) versus porcine surfactant, Poractant Alfa in the treatment of respiratory distress syndrome in preterm infants: A multicenter, double blind randomized clinical trial
R. Ramanathan¹, M. Biniwale¹, K. Sekar², N. Hanna³, S. Golombek⁴, J. Bhatia⁵, M. Naylor⁶, L. Fabbri⁷, D. Santoro⁷, A. Piccinno⁷, C. Dammann⁸ (¹Los Angeles; ²Oklahoma; ³Stony Brook; ⁴Valhalla; ⁵Augusta; ⁶Greenville, USA; ⁷Parma, Italy; ⁸Boston, USA)

11:15

Synthetic surfactant preparations containing a recombinant SP-B and SP-C analogue are efficient against respiratory distress syndrome in a premature rabbit model
O. Basabe-Burgos¹, A. Rising^1,2, T. Curstedt³, J. Johansson¹ (¹Huddinge; ²Uppsala; ³Stockholm, Sweden)

11:30

Dose-dependent improvement of lung function after nebulized poractant alfa administration to lung-lavaged, spontaneously-breathing adult rabbits with respiratory distress
F. Ricci¹, C. Catozzi¹, X. Murgia², M. Simonato³, B. Rosa^1,4, G. Pieraccini⁴, G. Moneti⁴, L. Lorenzini¹, F. Bianco¹, S. Catinella¹, G. Villetti¹, M. Civelli¹, B. Pioselli¹, P. Cogo³, V. Carnielli⁵,C. Dani⁴, F. Salomone¹ (¹Parma, Italy; ²Saarbrücken, Germany; ³Udine; ⁴Florence; ⁵Ancona, Italy)

11:45

Synthetic surfactant with SP-B and SP-C analogues (CHF5633) improves lung function and attenuates inflammation in an adult rabbit model of acute respiratory distress syndrome
P. Mikolka^1,2, T. Curstedt³, R. Feinstein⁴, A. Larsson⁴, A. Rising^1,4, J. Johansson¹ (¹Huddinge, Sweden; ²Martin, Slovakia; ³Stockholm; ⁴Uppsala, Sweden)

12:00

SPECIAL LECTURE

THE VOCALIST IN THE CRIB: DECODING NEONATES’ CRYING
Kathleen Wermke, Wuerzburg, Germany

12:30

LUNCH BREAK

13:30

POSTER PRESENTATIONS

Chairpersons: Corrado Moretti, Rome, Italy; Kris Sekar, Oklahoma City, USA

Lung deposition of nebulized poractant alfa in spontaneously-breathing newborn piglets: Comparison of CPAP versus pressure support ventilation via nasal prongs
A. Nord¹, R. Linner¹, F. Salomone², F. Bianco^2, F. Ricci ², X. Murgia³ et al. (¹Lund, Sweden; ²Parma, Italy; ³Saarbrücken Germany)

Is lung ultrasound more valuable than X-ray in evaluating the need of surfactant in preterm neonates?
G. Kayki, S. Yigit, H.T. Celik, M. Yurdakok (Ankara, Turkey)

Lung ultrasound in diagnosis and follow-up of neonatal pneumonia
A. Zenciroğlu, A. Öktem, S. Aydoğan, Ç. Üner, D. Dilli, N. Okumuş (Ankara, Turkey)

Characterization of in vitro performance of the customized eFlow neos nebulizer system with poractant alfa under simulated respiratory distress tidal breathing through a realistic neonatal upper airway replica
M. Nutini¹, S. Minocchieri², A. Bucholski³, M. Schlun³, U. Hetzer³, S. Bonelli¹ et al. (¹Parma, Italy; ²Winterthur, Switzerland; ³Starnberg, Germany)

Nebulized poractant alfa reduces the risk of respiratory failure at 72 hours in spontaneously-breathing surfactant- deficient newborn piglets
C. Rey-Santano¹, V. Mielgo¹, M.A. Gomez¹, F. Salomone², F. Bianco², B. Loureiro³ (^1,3Barakaldo, Bizkaia, Spain; ²Parma, Italy)

Surfactant administration by the LISA method: 5 years of experience at the Neonatal Resuscitation Centre of the Tivoli University Hospital in Belgium
J. Van Poucke, G. Malfilâtre, J. De Buyst, E. Strebelle, M. Janssens, C. Djeunang et al. (La Louvière, Belgium)

Chairpersons: Sture Andersson, Helsinki, Finland; Roger Soll, Burlington, USA

14:30

LUNG GROWTH IN PRETERM INFANTS
Virgilio Carnielli, Ancona, Italy

15:00

NECROTIZING ENTEROCOLITIS, GUT MICROBIOTA AND BRAIN DEVELOPMENT: ROLE OF GUT-BRAIN AXIS
Boris W. Kramer, Maastricht, The Netherlands

15:30

FREE COMMUNICATIONS

15:30

Hyperoxia injury of saccular stage lung results in mesenchymal expression of WNT5A
J.Sucre, M. Ransom, Z. Anderson, B. Fensterheim, A. Cutrone, C. Jetter, S. Guttentag (Nashville, United States)

15:45

Supplemental oxygen in the first 12 hours of life and less invasive surfactant administration (LISA)
E. Herting¹, C. Härtel¹, A. Kribs²,  W. Göpel¹(Lübeck¹;  Cologne², Germany)

16:00

COFFEE BREAK

Chairpersons: Neena Modi, London, UK; Rangasamy Ramanathan, Los Angeles, USA

16:30

NEW ESPGHAN GUIDELINES FOR TOTAL PARENTERAL NUTRTION IN NEONATES
Jatinder Bhatia, Augusta, USA

17:00

NEW GUIDELINES FOR THE TREATMENT OF NEONATAL RDS
David G. Sweet, Belfast, UK

17:30

Discussion

18:00

CLOSING REMARKS
Scientific Committee